Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles

OBiO Raises $28 Million for Viral Vector CRO/CDMO Operations
Asieris Approved to Start Global Phase III Trials of Cervical Lesion Treatment
Zai Lab In-licenses NSCLC Candidate from Turning Point in $178 Million Deal
Evive Bio Reports Positive Late-Stage Results on Neutropenia Treatment
Livzon In-Licenses Schizophrenia Patch Product from Germany's LTS
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China